Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy
JAMA · 17.09.2024 · 332 (11) · 906
DOI: 10.1001/jama.2024.15196 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 17.09.2024. Verfasst von US Preventive Services Task Force und 16 weiteren Autor:innen. Beteiligte Einrichtung: George Washington University, Washington, DC. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Dietary Supplements, Pregnancy Complications, Hematologic, Mass Screening. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance Iron deficiency is the leading cause of anemia during pregnancy. According to survey data from 1999 to 2006, overall estimated prevalence of iron deficiency during pregnancy is near 18% and increases across the 3 trimesters of pregnancy (from 6.9% to 14.3% to 28.4%). An estimated 5% of pregnant persons have iron deficiency anemia. Objective The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the evidence on the benefits and harms of screening and supplementation for iron deficiency with and without anemia on maternal and infant health outcomes in asymptomatic pregnant persons. Population Asymptomatic pregnant adolescents and adults. Evidence Assessment The USPSTF concludes that the current evidence is insufficient, and the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in asymptomatic pregnant persons on maternal and infant health outcomes cannot be determined. The USPSTF also concludes that the current evidence is insufficient, and the balance of benefits and harms of iron supplementation in asymptomatic pregnant persons on maternal and infant health outcomes cannot be determined. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine supplementation for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes. (I statement)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- George Washington University, Washington, DC.
- Brown University, Providence, Rhode Island.
- Tufts University School of Medicine, Boston, Massachusetts.
- Virginia Commonwealth University, Richmond.
- University of Washington, Seattle.
- University of Maryland School of Medicine, Baltimore.
Förderung
- NIA NIH HHS
Zitieren
APA
US Preventive Services Task Force, Nicholson, W. K., Silverstein, M., Wong, J. B., Chelmow, D., Coker, T. R., Davis, E. M., Jaén, C. R., Krousel-Wood, M., Lee, S., Li, L., Rao, G., Ruiz, J. M., Stevermer, J., Tsevat, J., Underwood, S. M., & Wiehe, S. (2024). Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy. JAMA, 332(11), 906. https://doi.org/10.1001/jama.2024.15196
Vancouver
US Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Chelmow D, Coker TR, et al. Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy. JAMA. 2024;332(11):906. doi:10.1001/jama.2024.15196
BibTeX
@article{USPreventiveServicesTaskForce2024,
author = {US Preventive Services Task Force, US Preventive Services Task Force and Nicholson, Wanda K and Silverstein, Michael and Wong, John B and Chelmow, David and Coker, Tumaini Rucker and Davis, Esa M and Jaén, Carlos Roberto and Krousel-Wood, Marie and Lee, Sei and Li, Li and Rao, Goutham and Ruiz, John M and Stevermer, James and Tsevat, Joel and Underwood, Sandra Millon and Wiehe, Sarah},
title = {Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy},
journal = {JAMA},
year = {2024},
volume = {332},
number = {11},
pages = {906},
doi = {10.1001/jama.2024.15196}
}
EUVIMED